| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/03/2013 | CN103006566A Osmotic pump controlled release tablet of losartan potassium and hydrochlorothiazide solid dispersion or inclusion compound |
| 04/03/2013 | CN103006565A Nano granular medicinal composition and preparation method thereof |
| 04/03/2013 | CN103006564A Thermally-stable sweet wormwood solid dispersion composition and preparation method thereof |
| 04/03/2013 | CN103006560A Hyaluronic acid oligosaccharide encased paclitaxel liposome and preparation method thereof |
| 04/03/2013 | CN103006559A Doramectin injection and preparation method thereof |
| 04/03/2013 | CN103006558A Cabazitaxel lipid microsphere injection and preparation method thereof |
| 04/03/2013 | CN103006557A Mitomycin A micelle preparation and preparation method as well as application thereof |
| 04/03/2013 | CN103006556A Scutellarin nanosuspension and preparation method thereof |
| 04/03/2013 | CN103006553A Luteolin solution composition |
| 04/03/2013 | CN103006548A Ambroxol hydrochloride glucose injection and preparation method thereof |
| 04/03/2013 | CN103006546A Preparation and application of carbon nano tube-containing thermo-sensitive type gel entrapping for indissolvable drug |
| 04/03/2013 | CN103006542A Platycodin D sperm-killing contraceptive suppository for external use and placing device thereof |
| 04/03/2013 | CN103006540A Stable pharmaceutical composition containing factor VIII |
| 04/03/2013 | CN103006539A Polymeric micelle medicine composition and preparation method thereof |
| 04/03/2013 | CN103006537A Gel preparation for treating psoriasis and preparation method thereof |
| 04/03/2013 | CN103006535A Methotrexate (MTX)-Pluronic copolymer mixed micelle carrying indissoluble medicament and preparation method thereof |
| 04/03/2013 | CN102697801B Manufacturing process of flavouring-containing medicinal mirabilite |
| 04/03/2013 | CN102406621B Freeze-dried powder injection for treating hepatopathy |
| 04/03/2013 | CN102389399B Preparation method of drug-loaded microspheres capable of enhancing anticancer effect of paclitaxel by ultraviolet radiation and application thereof |
| 04/03/2013 | CN102389393B Pefloxacin mesylate emulsion and preparation method thereof |
| 04/03/2013 | CN102370612B Chitosan-monomethoxy polyethylene glycol gel delivery system and preparation method thereof |
| 04/03/2013 | CN102344409B Amlodipine crystal, medicine composition of amlodipine crystal and benazepril as well as method for preparing medicine composition |
| 04/03/2013 | CN102335229B Preparation method of gynecological inflammation clearing vaginal effervescent tablet |
| 04/03/2013 | CN102327218B Cefdinir liposome solid preparation |
| 04/03/2013 | CN102319227B Lomerizine hydrochloride osmotic pump tablet and preparation method thereof |
| 04/03/2013 | CN102319225B Trimetazidine hydrochloride sustained release tablet and preparation method thereof |
| 04/03/2013 | CN102311512B Cyclodextrin-aliphatic polyester-phosphatidyl ethanolamine graft polymer and preparation method thereof |
| 04/03/2013 | CN102274182B Multivesicular liposome containing exenatide, preparation method and application thereof |
| 04/03/2013 | CN102210665B Method for preparing feed antibacterial agent by absorbing and grafting potassium diformate on epidesmine molecular screen |
| 04/03/2013 | CN102188397B Tetracaine hydrochloride multi-vesicular liposome freeze-dried powder and preparation method thereof |
| 04/03/2013 | CN102188396B Lyophilized potassium sodium dehydroandroan drographolide succinate multi-vesicular liposome (MVL) powder and preparation method thereof |
| 04/03/2013 | CN102133173B Moxidectin pour sprinkling preparation and preparation method thereof |
| 04/03/2013 | CN102120755B Brown adipose tissue targeted polypeptide and applications thereof |
| 04/03/2013 | CN102091326B Transdermal medicament delivery preparation for treating hemorrhoid diseases caused by expansion or varix of anal subcutaneous veniplex and preparation method thereof |
| 04/03/2013 | CN102091097B Washing-free puerpera perineum medical-care gel and preparation method thereof |
| 04/03/2013 | CN101987082B Solid preparation and preparation method thereof |
| 04/03/2013 | CN101947200B Emulsion type ointment |
| 04/03/2013 | CN101926773B Medicament-carrying lipoid particulates and preparation method thereof |
| 04/03/2013 | CN101919865B Capsule type budesonide dry powder inhalation and preparation process thereof |
| 04/03/2013 | CN101897683B Transdermal hormone delivery system: compositions and methods |
| 04/03/2013 | CN101891783B Flavone-metal complex microsphere and preparation method and application thereof |
| 04/03/2013 | CN101861148B Lidocaine tape preparation |
| 04/03/2013 | CN101831272B Dipeptide derivative gel and preparation method thereof |
| 04/03/2013 | CN101801414B Oral and skin compositions |
| 04/03/2013 | CN101721594B Chinese medicinal ointment with antibacterial and antipruritic effects and preparation method thereof |
| 04/03/2013 | CN101695477B Method for preparing potato starch medicament carrier microspheres |
| 04/03/2013 | CN101583379B Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles |
| 04/03/2013 | CN101553257B Adhesive skin patch and method for evaluation of adhesive skin patch |
| 04/03/2013 | CN101287499B Use of therapeutically effective lipids and method for producing organ-/tissue-specific therapeutical effective lipids |
| 04/03/2013 | CN101242859B N,N-bis-(2-hydroxyethyl) glycine amide as linker in polymer conjugated prodrugs |
| 04/03/2013 | CN101172104B Processes of making and using pharmaceutical formulations of antineoplastic agents |
| 04/02/2013 | US8410180 Methods to treat urinary incontinence |
| 04/02/2013 | US8409621 Forming controlled release, core shell drug delivery materials; charge voltage accelerating second liquid stream to surround first stream and vibrating |
| 04/02/2013 | US8409618 Fiber substrate with odor absorbent |
| 04/02/2013 | US8409617 Vitamin powder composition and method of making |
| 04/02/2013 | US8409613 Gastric retained gabapentin dosage form |
| 04/02/2013 | US8409612 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 04/02/2013 | US8409610 Wound care device |
| 04/02/2013 | US8409605 Biocompatible material composition adaptable to diverse therapeutic indications |
| 04/02/2013 | US8409586 Stable liquid formulation of human growth hormone |
| 04/02/2013 | US8409561 Methods and compositions for treatment of ion imbalances |
| 04/02/2013 | CA2632067C Method for improving absorbability of epigallocatechin gallate, foods, drinks and food/drink materials using the same and method for producing the same |
| 04/02/2013 | CA2569067C Unagglomerated core/shell nanocomposite particles |
| 04/02/2013 | CA2565424C Macromolecule-containing sustained release intraocular implants and related methods |
| 04/02/2013 | CA2556248C Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells |
| 04/02/2013 | CA2555792C Therapeutic administration of the scrambled anti-angiogenic peptide c16y |
| 04/02/2013 | CA2512730C Hydroxyphenyl cross-linked macromolecular network and applications thereof |
| 04/02/2013 | CA2502948C Modified bio-related substance, process for producing the same, and intermediate |
| 04/02/2013 | CA2494105C Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 04/02/2013 | CA2491724C Ciclesonide-containing sterile aqueous suspension |
| 04/02/2013 | CA2470920C Liposomal delivery of vitamin e based compounds |
| 04/02/2013 | CA2452529C Use of a blood-flow decrease preventing agent in conjunction with insufflating gas |
| 04/02/2013 | CA2449412C Receptor-mediated uptake of peptides that bind the human transferrin receptor |
| 04/02/2013 | CA2420652C Vertebrate intestinal protein which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 04/02/2013 | CA2420543C Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 03/28/2013 | WO2013044219A1 Methods of treating cancers with therapeutic nanoparticles |
| 03/28/2013 | WO2013044116A1 Antimicrobial compositions and methods of use thereof |
| 03/28/2013 | WO2013044098A1 Compositions and methods for treating conditions of compromised skin barrier function |
| 03/28/2013 | WO2013044058A1 Mitochondria-targeted antioxidants for treatment of age-related brain disorders |
| 03/28/2013 | WO2013043839A1 Biosensor with error compensation |
| 03/28/2013 | WO2013043812A1 Logical enzyme triggered (let) layer-by-layer nanocapsules for drug delivery system |
| 03/28/2013 | WO2013043387A1 Ophthalmic gel compositions |
| 03/28/2013 | WO2013042834A1 Radionuclide marked and drug carrying polymer hydrogel and a production method therefor, and pharmaceutical composition for treating cancer comprising same as an active ingredient |
| 03/28/2013 | WO2013042122A1 Beta-lactam compounds for enhancing t cell -mediated immune responses |
| 03/28/2013 | WO2013042121A1 Beta-lactam compounds for treating diabetes |
| 03/28/2013 | WO2013041606A1 Pyrrolobenzodiazepines as unsymmetrical dimeric pbd compounds for inclusion in targeted conjugates |
| 03/28/2013 | WO2013041572A1 Liposome production using isopropanol |
| 03/28/2013 | WO2013041542A1 Pharmaceutical formulations comprising spherolyophilisates of biological molecules |
| 03/28/2013 | WO2013041500A1 Microbubble complexes and methods of use |
| 03/28/2013 | WO2013041029A1 Novel soluble ctla4 variants |
| 03/28/2013 | WO2013040873A1 Sustained and controlled release of micro-granule formulation for treating intestinal disease and preparation method thereof |
| 03/28/2013 | WO2013006692A3 Methods of treatment using a pentapeptide derived from the c-terminus of glucagon-like peptide 1 (glp-1) |
| 03/28/2013 | WO2012165916A3 Non-peptidyl polymer-insulin multimer and method for producing the same |
| 03/28/2013 | WO2012165915A3 Composition for treating diabetes comprising long-acting insulin conjugate and long-acting insulinotropic peptide conjugate |
| 03/28/2013 | WO2012159077A9 Multiple dosing regimen oral drug delivery platform |
| 03/28/2013 | WO2012158622A3 Reversibly crosslinked micelle systems |
| 03/28/2013 | WO2012140647A3 Albumin binding probes and drug conjugates thereof |
| 03/28/2013 | WO2012057212A9 Percutaneous absorption type formulation |
| 03/28/2013 | WO2011103920A3 Pharmaceutical or neutraceutical formulation |
| 03/28/2013 | US20130079555 Thiol-Selective Water-Soluble Polymer Derivatives |